Cargando…
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is characterized by a high possibility of metastasis. M2-like tumor-associated macrophages (TAMs) are the main components of the tumor microenvironment (TME) and play a key role in TNBC metastasis. Therefore, TAMs may be a potential target for reducing TNBC metas...
Autores principales: | Kim, Soyoung, Choi, Ilseob, Han, Ik-Hwan, Bae, Hyunsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779714/ https://www.ncbi.nlm.nih.gov/pubmed/36555393 http://dx.doi.org/10.3390/ijms232415751 |
Ejemplares similares
-
Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
por: Han, Ik-Hwan, et al.
Publicado: (2022) -
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
por: Lee, Chanju, et al.
Publicado: (2022) -
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages
por: Jeong, Chanmi, et al.
Publicado: (2023) -
TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Lee, Chanju, et al.
Publicado: (2022) -
Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
por: Lee, Chanju, et al.
Publicado: (2019)